Millipore Drops 6% on Lowered Revenue Expectations

Millipore (MIL) , a provider of services for companies developing new therapeutic drugs, expects first-quarter earnings of 38 cents to 42 cents a share, but the company said its revenue will come in lower than anticipated. Analysts expect earnings of 40 cents. The shares were losing 6.6% to $40.90.